Binnacle Investments Inc Exact Sciences Corp Transaction History
Binnacle Investments Inc
- $137 Billion
- Q1 2025
A detailed history of Binnacle Investments Inc transactions in Exact Sciences Corp stock. As of the latest transaction made, Binnacle Investments Inc holds 9 shares of EXAS stock, worth $480. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9Holding current value
$480% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding EXAS
# of Institutions
657Shares Held
158MCall Options Held
3.12MPut Options Held
2.12M-
Capital World Investors Los Angeles, CA17.8MShares$952 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$942 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.5MShares$668 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$644 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.4MShares$342 Million0.03% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $9.45B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...